These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3101340)

  • 41. Exercise and hormonal secretion.
    Gawel MJ; Park DM; Alaghband-Zadeh J; Rose FC
    Postgrad Med J; 1979 Jun; 55(644):373-6. PubMed ID: 482180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anterior pituitary functions in patients with uremia tested by stimulation with four combined hypothalamic releasing hormones.
    Lee YJ; Tsai JH; Lai YH; Torng JK; Shin SJ; Wu CC
    Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1091-6. PubMed ID: 2561485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma and pituitary content of growth hormone luteinizing hormone, and prolactin in uremic rats. Effects of chronic infusion of insulin.
    Lacour B; Roullet JB; Bluet-Pajot MT; Yvert JP; Drüeke T; Durand D
    Nephron; 1986; 44(3):235-9. PubMed ID: 3537818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of an acute injection of melatonin on the basal secretion of hypophyseal hormones in prepubertal and pubertal healthy subjects.
    Lisoni P; Resentini M; Mauri R; De Medici C; Morabito F; Esposti D; Di Bella L; Esposti G; Rossi D; Parravicini L
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):305-11. PubMed ID: 3083625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
    J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
    Kopelman PG; Noonan K; Goulton R; Forrest AJ
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth hormone responses to growth hormone-releasing hormone, clonidine and insulin-induced hypoglycemia in normal weight bulimic women.
    Coiro V; Capretti L; Volpi R; d'Amato L; Marchesi C; De Ferri A; Rossi G; Bianconi L; Marcato A; Chiodera P
    Neuropsychobiology; 1990; 23(1):8-14. PubMed ID: 2126361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of erythropoietin on gonadotropin responses to gonadotropin-releasing hormone in uremic patients.
    Díez JJ; Iglesias P; Bajo MA; de Alvaro F; Selgas R
    Nephron; 1997; 77(2):169-75. PubMed ID: 9346383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Behavior of the hypothalamo-hypophyseal unit to stimulation with arginine, GnRH and TRH in patients with chronic uremia].
    Rudolf K; Kunkel S; Rudolf H; Falkenhagen D; Rüting M; Osten B
    Zentralbl Gynakol; 1985; 107(24):1510-9. PubMed ID: 3937374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circadian responsiveness of the hypothalamic-pituitary axis.
    Rastogi GK; Dash RJ; Sharma BR; Sawhney RC; Sialy R
    J Clin Endocrinol Metab; 1976 May; 42(5):798-803. PubMed ID: 818101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
    Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
    Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.
    Iglesias P; Selgas R; Méndez J; Fernández-Reyes MJ; Bajo MA; Aguilera A; Díez JJ
    Nephrol Dial Transplant; 2000 Jun; 15(6):856-61. PubMed ID: 10831641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carpenter's syndrome with empty sella and abnormal LRH and TRH response.
    Verdy M; Dussault RG; Verrault R; Bolté E
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):6-9. PubMed ID: 6312721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prolactin response to acute administration of growth hormone releasing hormone in patients with uremia].
    García Martín F; Donnay Candil S; Martín Escobar E; Alvaro R; de Arriba G; Requejo R; Martín Hernández R
    Rev Clin Esp; 1989 Nov; 185(8):399-401. PubMed ID: 2516347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition by phospholipid liposomes of the prolactin and cortisol response to insulin hypoglycemia in man.
    Cavagnini F; Maraschini C; Dubini A; Ramella G; Danesi L; Fossati R
    Psychopharmacology (Berl); 1984; 82(3):157-60. PubMed ID: 6425893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in pituitary secretion induced by an agonist-antagonist opioid drug, buprenorphine.
    Rolandi E; Marabini A; Franceschini R; Messina V; Bongera P; Barreca T
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):257-60. PubMed ID: 6415992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific inhibition by somatostatin of growth hormone release after hypoglycaemia in normal man.
    Copinschi G; Virasoro E; Vanhaelst L; Leclercq R; Golstein J; L'Hermite M
    Clin Endocrinol (Oxf); 1974 Oct; 3(4):411-5. PubMed ID: 4609639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.